LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Repeat performed by Scientist B in 2019 to assess reproducibility. Dataset 1 of 2: Normalized growth rate inhibition values. - Dataset (ID:20359)

Filter results: >>>>
Small Molecule barcode cell_count frac_dead corpse_count cell_count_dead row column agent concentration role timepoint replicate cell_line dead_count fraction_dead cell_count__time0 dead_count__time0 cell_count__ctrl dead_count__ctrl fraction_dead__ctrl increase_fraction_dead GRvalue
Neratinib
180622_BG_8
21170 0.0268 56 513 11 22
Neratinib
0.001081167
treatment
72 2
MCF10A-GM_8
569 0.0262 832.0 168.3 20016 537.9 0.0261 0.00005 1.0246
Vorinostat
180703_BG_10
22679 0.0345 62 723 5 13
Vorinostat
0.003326667
treatment
72 3
MCF10A-GM_1
785 0.0335 1387.8 74.9 21564 711.9 0.0318 0.00166 1.0256
Taxol
180614_BG_04
18063 0.0199 70 290 9 20
Paclitaxel
0.000332667
treatment
72 1
MCF10A-GM_7
360 0.0195 889.0 105.5 17054 348.0 0.0200 -0.00045 1.0272
Etoposide
180622_BG_8
21315 0.0229 52 438 11 4
Etoposide
0.003326667
treatment
72 2
MCF10A-GM_7
490 0.0225 832.0 168.3 20016 537.9 0.0261 -0.00365 1.0276
Neratinib
180622_BG_8
21382 0.0280 44 556 9 12
Neratinib
0.00998
treatment
72 2
MCF10A-GM_8
600 0.0273 832.0 168.3 20016 537.9 0.0261 0.00117 1.0290
Neratinib
180614_BG_02
18291 0.0179 24 304 9 8
Neratinib
0.003326667
treatment
72 1
MCF10A-GM_2
328 0.0176 889.0 105.5 17054 348.0 0.0200 -0.00238 1.0331